ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.84
+6.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.22x
- Price / sales
- 4.55x
- Price / cash flow
- -0.30x
Enterprise value
- Enterprise value
- -$2.1M
- EV / sales
- -4.40x
- EV / EBITDA
- 0.20x
- EV / EBIT
- 0.22x
- Market cap
- $2.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026